⌘K

Login Start Free

Home/Filings/4/0001933414-23-000079

4//SEC Filing

Karydas Daphne 4

Accession 0001933414-23-000079

CIK 0001933414other

View on SEC.gov Company Profile

Filed

Sep 13, 8:00 PM ET

Accepted

Sep 14, 4:13 PM ET

Size

5.3 KB

Accession

0001933414-23-000079

Insider Transaction Report

Form 4

Period: 2023-09-13

Mineralys Therapeutics, Inc.MLYS

Director

Transactions

Award
Stock Option
2023-09-13+44,000→ 44,000 total
Exercise: $12.02Exp: 2033-09-13→ Common Stock (44,000 underlying)

Footnotes (1)

[F1]The stock option vests in 36 monthly installments beginning on October 13, 2023.

Documents

1 file

4
wf-form4_169472241630395.xmlPrimary
FORM 4

Issuer

Mineralys Therapeutics, Inc.

CIK 0001933414

Entity typeother

Related Parties

1

filerCIK 0001816952

Filing Metadata

Form type: 4
Filed: Sep 13, 8:00 PM ET
Accepted: Sep 14, 4:13 PM ET
Size: 5.3 KB

View on SEC.gov